Formulation And Evaluation Of Nyctanthes Arbor-Tristis Leaf Extract Loaded Microemulsion For Anti Inflammantory Activity

Therapeutic effectiveness, safety, and patient acceptance of herbal medicines have led to their increasing interest in the field. The use of natural products to treat acute and chronic illnesses is due to their significant contribution of bioactive compounds. The clinical applications of numerous herbal constituents are limited due to their poor solubility, low permeability (fecal matter increase), low bioavailability, and instability, despite their significant pharmacological potential. Improved drug delivery systems are now a viable option to overcome these limitations and enhance therapeutic outcomes.
Oil, water, surfactant and co-surfactante are the components of microemulsions – they are thermodynamically stable, transparent dispersions. The nanometer-sized droplets and high solubilization capacity of microemulsions make them a better choice for drug dissolution, absorption, controlled release, and bioavailability. These benefits enable them to be used as carriers for both synthetic and herbal therapeutic agents. Night Jasmine, Har-tristis or Parijat are also known as members of the Oleaceae family (Nyctanthes arbor-tigristinis Linn.). Traditional Ayurvedic medicine has made the plant a popular remedy for treating fever, arthritis, inflammation, skin disorders, and various infectious diseases. Flavonoids, glycosides and alkaloids along with tannins, phenolic compounds and iridoid glycodes are among the phytoconstituents found in different parts of the plant, such as leaves (including their color), flowers, seeds and bark. It has various pharmacological activities, including anti-inflammatory, antioxidant (antibiotic), hepatoprotective, antimicrobial, and immunomodulatory effects.
Inflammation is the complex biological response caused by tissue injury, infection or immune-mediated reactions. A range of pathological conditions, including rheumatoid arthritis and other cardiovascular disorders as well as diabetes and neurodegenerative diseases, are linked to chronic inflammation. Conventional anti-inflammatory drugs can provide symptomatic relief, but their use is frequently associated with side effects.  There's a growing trend of developing safer and more effective alternatives to traditional medicine.
It is possible to increase the solubility, stability, and bioavailability of the active phytoconstituents by adding leaf extract from Nyctanthes arbor-tristis to a microemulsion system. This may enhance therapeutic efficacy while minimizing the effects of dose-dependent limitations. This study aimed to develop and test a microemulsion infused with leaf extracts of Nyctanthes arbor-tristis, which could be used as inflammatory antidepressant.

AIM OF THE STUDY

To produce and test a new microemulsion using the leaf extract of Nyctanthes arbor-tristi, that is more effective in anti-inflammatory activities.

Objectives

1. Prepare and describe the leaf extract of Nyctanthes arbor-tristis.

2. Using appropriate excipients, microemulsion systems are created.

3. To examine the physicochemical features of the prepared compounds.

4. To ascertain the drug content and release properties of in vitro drugs.

5. Assessing the stability of a formulation during storage.

6. Considering the possibility of using microemulsion as an anti-inflammatory agent.

MATERIALS AND METHODS:

1. Plant Material Collection and Authentication

In a local area of Madhya Pradesh, India, fresh leaves of Nyctanthes arbor-tristis Linn. were discovered in the field. To remove dust and foreign matter from the plant material, distilled water was used to wash it thoroughly. They shade-dried the leaves at room temperature before grinding them finely in a mechanical grinder. The final outcome: powdered leaves. Powdered material was kept in sealed containers until it could be used again.

2. Preparation of Leaf Extract

The extracted dried leaf powder was filtered through a suitable solvent system. This extraction was made using the maceration/soxhlet extraction method. A rotary evaporator was utilized to filter and concentrate the extract under reduced pressure. We then dried the concentrated extract, weigh it and put it in a desiccator to be used for further study of its formulations.

3. Preliminary Phytochemical Screening

Qualitative phytochemical screening was performed on the prepared extract to identify various secondary metabolites.'... Standard phytochemical tests were administered for:

• Alkaloids.
• Flavonoids.
• Glycosides.
• Phenolic compounds.
• Tannins.
• Saponins.
• Terpenoids.
• Carbohydrates.

Phytoconstituents were assessed in terms of color changes or precipitation, with respect to their presence and absence.

4. Selection of Excipients

Various oils, surfactants and co-surfactant were also used for the solubilisation of extract from Nyctanthes arbor-tristis.

• Oil Phase

The optimal oil for the extract was selected due to its maximum solubility.

• Surfactant
  Its emulsification efficiency and safety made it the preferred choice for a non-ionic surfactant.
• Co-Surfactant
  The co-surfactant used was chosen to make the interfacial film more flexible and allow for the formation of microemulsion.).

5. Preparation of Microemulsion

Water titration was employed to create microemulsion formulations. The mixture of oil, surfactant, and co-surfactante was weighed accurately to ensure a homogeneous blend. This extracted became dispersed in the chosen oil phase. By adding distilled water and stirring it continuously until a stable and transparent microemulsion system was achieved, the process continued.
The concentration of oil, surfactant, and co-surfactante was adjusted to achieve an optimized formulation by preparing different variants (F1–F5).

6. Construction of Pseudo-Ternary Phase Diagram.

Pseudo-ternary phase diagrams were created by utilizing different proportions of surfactant and co-surfactants (Smix). A water titration method was employed to pinpoint the microemulsion area. The clear and isotropic zone was deemed appropriate for formulation advancement.

7. Evaluation of Microemulsion

7.1. Physical Appearance

A visual examination was conducted on the prepared formulations:

• Transparency.
• Color.
• Phase separation.
• Homogeneity.

7.2 pH Determination

The pH of each formulation was measured by a digital pH meter that was calibrated at room temperature. The average was reported after three measurements were made.

7.3. Viscosity Measurement

At controlled temperatures, a Brookfield viscometer was employed to measure viscosity. A total of three measurements were taken.

7.4. Globule Size Analysis

Dynamic Light Scattering (DLS) techniques were utilized to establish the typical size of individual droplets in the microemulsion. They were then measured, with distilled water in proper dilation.

7.5. Polydispersity Index (PDI)

To ensure a consistent distribution of droplet sizes in the formulation, PDI values were recorded.

7.6. Zeta Potential Analysis

Using the zeta potential analyzer, they determined the physical stability of the developed microemulsion.

7.7. Drug Content Determination

By using UV-Visible spectroscopy, the microemulsion was diluted with a suitable solvent and subject to an accurate measurement. A calibration curve was utilized to determine the drug content of extract.

7.8. In Vitro Drug Release Study.

Drug release in vitro was studied using a membrane diffusion dialysis technique.

Procedure:

• The dialysis membrane contained a specific amount of formulation.
• Dissolving medium at 37 0.5 °C was used to immerse the membrane.
• Dissolving medium at 37 0.5 °C was used to immerse the membrane.
• The withdrawal of samples was arranged in stages.
• The fresh medium was replaced in equal amounts after each sample.
• Samples were subjected to UV-Visible spectrophotometry.

The cumulative amount of drugs released was calculated and plotted against time.

8. Stability Studies

According to ICH guidelines, stability studies were conducted on the optimized formulation.
Storage conditions included:

• Refrigerated condition (4°C ± 2°C)
• Room temperature (25°C ± 2°C)
• Temporal acme (40°C 2°Cu / 75% RH)

Samples were evaluated periodically for:

• Appearance.
• PH.
• Drug content.
• Phase separation.
• Drug release behavior.

9. Statistical Analysis

All experiments were run in triplicate and the results were expressed as Mean Standard Deviation (SD).. The significance of p 0.05 was determined through statistical analysis using appropriate software.

RESULTS AND DISCUSSION:

1. Phytochemical Screening
   The bioactive components found in the leaf extract of Nyctanthes arbor-tristis were identified through preliminary phytochemical analysis, indicating its ability to perform therapeutic functions. Flavonoids, phenolic compounds, glycosides, alkaloids , tannins and terpenoids were all positively affected by the extract.

The plant extract is rich in flavonoids and phenolic compounds, which contribute to its anti-inflammatory and antioxidant properties.

2. Solubility Studies

In order to prepare microemulsions, soluble factors were identified through the study of reabsorption properties. It was used for formulation development because the selected oil phase, surfactant, and co-surflatant system in the extract exhibited maximum solubility.
These selected excipients facilitate stable microemulsion formation and efficient solubilization of phytoconstituents

3. Construction of Pseudo-Ternary Phase Diagram

The microemulsion region was determined by using different Smix ratios and resulting pseudo-ternary phase diagrams.
This meant that at optimal surfactant/co-surfactants ratios a larger transparent region was observed, suggesting higher efficiency for the process of making emulsification and better thermodynamic stability.
Additional study on the composition of compounds was conducted with the recommended Smix ratio.

Fig 1: Pseudoternary Phase Diagram

Fig 2: In vitro drug release graph

Drug Release Data

DISCUSSION

The rate of drug release for all formulations increased gradually over time.

The highest cumulative drug release was attributed to the optimized formulation (F5), which are:

• Smaller droplet size.
• Improved drug solubilization.
• Enhanced diffusion characteristics.

By using a microemulsion system, the release behavior of the herbal extract was improved.

10. Stability Studies

Stability tests for different storage conditions of the optimal formulation.

Observations

• No phase separation observed.
• No significant color change detected.
• The drug content was still within acceptable limits.
• PH was low, and viscosity slightly higher.

Stability Data

It was found that the formulation remained stable both physically and chemically throughout the study.

11. Overall Discussion

This study has been successful in creating a microemulsion with leaf extract from Nyctanthes arbor-tristis that exhibits favorable physicochemical traits. Excellent transparency, stability of drug loading capacity and demonstrated good sustained drug release behavior were also features of this optimized formulation.

Phytoconstituents solubilization is facilitated by the nanometric droplet size, which may lead to better bioavaility after administration. The formulation was well-suited for pharmaceutical applications due to its ability to withstand various storage conditions.
Herbal extracts can be effectively targeted for therapeutic purposes through microemulsion-based delivery systems, which are a promising new method of delivering anti-inflammatory drugs.

CONCLUSION

The present study has successfully created and tested a microemulsion containing leaf extracts from Nyctanthes arbor-tristis, which is now considered 'novel' for anti-inflammatory use as. These formulated microemulsions demonstrated desirable physiological properties, including transparency, homogeneity, pH stability, drug content, and distribution of nanometers.
The microemulsion system was modified to incorporate Nyctanthes arbor-tristis extract, which resulted in a significant enhancement of the bioactive phytoconstituents solubilization and release profile. The improved formulation demonstrated superior drug release behavior, satisfactory zeta potential, and good physical stability in storage experiments. The microemulsion system was found to effectively address the limitations posed by poor water solubility and bioavailability of herbal constituents, as evidenced by these results.

Phytochemical screening revealed the presence of various biologically active compounds, including flavonoids, phenolics, alkaloids and tannins as well as glycosides that have anti-inflammatory properties. A stable carrier system was created from the formulation, which could enhance phytoconstituents' therapeutic effects.

The results indicate that the application of microemulsion infused with leaf extracts from Nyctanthes arbor-tristis is a promising and efficient method for administering herbal drugs. This is quite significant. This formula could also improve anti-inflammatory efficacy and patient compliance, as well as help develop newer phytopharmaceuticals. Further in vivo pharmacological and clinical studies are recommended to prove the effectiveness of this therapy and its commercial potential.

ACKNOWLEDGEMENT:

The authors are sincerely grateful to Oriental University, Indore, Madhya Pradesh, for providing the necessary facilities and infrastructure in addition to academic assistance. The authors are notably grateful to Dr. Thanks to Vishakha Chauhan's valuable guidance, her unwavering backing and advice, as well as her supportive ear and positive management of the research. Additionally, the authors acknowledge the support of the faculty members and laboratory staff of Oriental University's Faculty of Pharmacy for their research.

CONFLICT OF INTEREST

There is no conflict of interest associated with the publication of this research work, as stated by the authors.

FUNDING

As per the authors, there was no outside funding for conducting this research work.

AUTHOR CONTRIBUTION

Shivansh Soni: Introduction, literature analysis, formulation, experimental design/conception, data collection, analysis and interpretation of results, as well as manuscript preparation.

Dr. Vishakha Chauhan: Research supervision, methodology validation, data interpretation, manuscript review, critical revision, and overall guidance throughout the study.
After reading and agreeing to publish the final manuscript, both authors have signed it.

ETHICAL APPROVAL

The study didn't involve any human subjects. Standard laboratory practices and institutional research guidelines were followed in all experimental procedures.

DATA AVAILABILITY STATEMENT

If requested by the corresponding author, they will provide data that supports the findings of this study.

REFERENCES

1. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 56th ed. Pune: Nirali Prakashan; 2021.
2. Harborne JB. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 3rd ed. London: Chapman and Hall; 1998.
3. Khandelwal KR. Practical Pharmacognosy. 25th ed. Pune: Nirali Prakashan; 2019.
4. Venkataraman S, Devi P, Sujatha R. Phytochemical constituents and pharmacological activities of Nyctanthes arbor-tristis: A review. Int J Pharm Sci Rev Res. 2019;56(2):45-53.
5. Saxena RS, Gupta B, Saxena KK. Anti-inflammatory activity of Nyctanthes arbor-tristis leaves. J Ethnopharmacol. 2002;81(3):321-325.
6. Das S, Sasmal D, Basu SP. Evaluation of anti-inflammatory activity of Nyctanthes arbor-tristis. Indian J Pharmacol. 2008;40(6):267-270.
7. Gupta A, Sharma S. Pharmacological activities of Nyctanthes arbor-tristis: A comprehensive review. Int J Pharm Sci Res. 2021;12(3):1120-1132.
8. Patel RP, Patel MM. Formulation and development of microemulsion drug delivery systems. Int J Pharm Sci Nanotechnol. 2014;7(2):2481-2490.
9. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2012;64:175-193.
10. Talegaonkar S, Azeem A, Ahmad FJ. Microemulsions: A novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul. 2008;2(3):238-257.
11. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption. Pharm Res. 1995;12(11):1561-1572.
12. Ghosh PK, Murthy RSR. Microemulsions: A potential drug delivery system. Curr Drug Deliv. 2006;3(2):167-180.
13. Kreilgaard M. Influence of microemulsions on drug bioavailability. Adv Drug Deliv Rev. 2002;54:S77-S98.
14. Sharma N, Bansal M, Visht S. Microemulsion as a promising drug delivery system. Int J Pharm Sci Rev Res. 2010;5(2):103-109.
15. Patel H, Vavia P. Preparation and characterization of microemulsions. Drug Dev Ind Pharm. 2007;33(8):871-880.
16. Ahuja A, Ali J, Baboota S. Design and development of herbal microemulsion systems. Int J Drug Deliv. 2011;3(2):236-245.
17. Kumar R, Singh A. Herbal drug delivery systems: Current status and future prospects. Asian J Pharm Clin Res. 2018;11(4):20-27.
18. Mukherjee PK. Quality Control of Herbal Drugs. 2nd ed. New Delhi: Business Horizons; 2007.
19. Ansari SH. Essentials of Pharmacognosy. New Delhi: Birla Publications; 2018.
20.  Jain NK. Controlled and Novel Drug Delivery. 1st ed. New Delhi: CBS Publishers; 2015.
21. Yadav N, Khatak S, Sara UVS. Comparative evaluation of herbal drug delivery systems. Int J Pharm Sci Res. 2013;4(6):2141-2148.
22. Gupta R, Sharma AK. Advances in herbal formulations and drug delivery approaches. J Drug Deliv Ther. 2020;10(2):191-198.
23. Singh S, Kumar A. Evaluation techniques for nano and microemulsion systems. Int J Pharm Investig. 2017;7(3):123-130.
24. Shah P, Bhalodia D, Shelat P. Stability studies of microemulsion formulations. Int J Pharm Pharm Sci. 2015;7(5):15-21.
25. World Health Organization. WHO Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. Geneva: WHO Press; 2007.
26. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. Ghaziabad: IPC; 2022.
27.  Aulton ME, Taylor K. Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 6th ed. London: Elsevier; 2022.
28.  Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 4th ed. New Delhi: CBS Publishers; 2013.
29. Sinko PJ. Martin's Physical Pharmacy and Pharmaceutical Sciences. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2017.
30. Allen LV, Popovich NG, Ansel HC. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems. 11th ed. Philadelphia: Wolters Kluwer; 2020.